Vivax malaria: A major cause of morbidity in early infancy

Clinical Infectious Diseases

Volumn 48, Issue 12, 2009, Pages 1704-1712

  Poespoprodjo, Jeanne R ^a,b   Fobia, Wendelina ^b   Kenangalem, Enny ^a,b   Lampah, Daniel A ^a,b   Hasanuddin, Afdal ^c   Warikar, Noah ^b,d   Sugiarto, Paulus ^c   Tjitra, Emiliana ^e   Anstey, Nick M ^f,g   Price, Ric N ^f,g,h,i  

^a District Health Authority   (Papua New Guinea)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Mitra Masyarakat Hospital   (Papua New Guinea)

^d International SOS ^*  (Papua New Guinea)

^e NATIONAL INSTITUTE OF HEALTH RESEARCH AND DEVELOPMENT   (Indonesia)

^f MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^g ROYAL DARWIN HOSPITAL   (Australia)

^h CHURCHILL HOSPITAL   (United Kingdom)

ⁱ School of Health Research   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ARTESUNATE; DIHYDROARTEMISININ PLUS PIPERAQUINE; QUININE;

ANEMIA; ARTICLE; DISEASE SEVERITY; EARLY DIAGNOSIS; FATALITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INDONESIA; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIDRUG RESISTANCE; NONHUMAN; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTOPENIA;

ANEMIA; ANIMALS; ENDEMIC DISEASES; FEMALE; HUMANS; INDONESIA; INFANT; INFANT, NEWBORN; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; PREVALENCE; PROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 66949112575     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/599041     Document Type: Article

References (35)

1. McGregor IA. Epidemiology, malaria and pregnancy. Am J Trop Med Hyg 1984;33:517-25.
2. Bruce-Chwatt LJ. Malaria in infants and children in Southern Nigeria. Ann Trop Med Parasitol 1952;46:173-99.
3. Riley EM, Wagner GE, Akanmori BD, Koram KA. Do maternally acquired antibodies protect infants from malaria infection? Parasite Immunol 2001;23:51-9.
4. Riley EM, Wagner GE, Ofori MF, et al. Lack of association between maternal antibody and protection of African infants from malaria infection. Infect Immun 2000; 68:5856-63.
5. Wagner G, Koram K, McGuinness D, Bennett S, Nkrumah F, Riley E. High incidence of asymptomatic malaria infections in a birth cohort of children less than one year of age in Ghana, detected by multicopy gene polymerase chain reaction. Am J Trop Med Hyg 1998; 59:115-23.
6. Afolabi BM, Salako LA, Mafe AG, et al. Malaria in the first 6 months of life in urban African infants with anemia. Am J Trop Med Hyg 2001; 65:822-7.
7. Slutsker L, Khoromana CO, Hightower AW, et al. Malaria infection in infancy in rural Malawi. Am J Trop Med Hyg 1996;55:71-6.
8. Kitua AY, Smith T, Alonso PL, et al. Plasmodium falciparum malaria in the first year of life in an area of intense and perennial transmission. Trop Med Int Health 1996; 1:475-84.
9. Ibhanesebhor SE. Clinical characteristics of neonatal malaria. J Trop Pediatr 1995;41:330-3.
10. Valecha N, Bhatia S, Mehta S, Biswas S, Dash AP. Congenital malaria with atypical presentation: a case report from low transmission area in India. Malar J 2007; 6:43.
11. Pengsaa K. Congenital malaria in Thailand. Ann Trop Paediatr 2007; 27:133-9.
12. Smith T, Genton B, Baea K, Gibson N, Narara A, Alpers MP. Prospective risk of morbidity in relation to malaria infection in an area of high endemicity of multiple species of Plasmodium.AmJTropMedHyg 2001; 64:262-7.
13. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. Vivax malaria: neglected and not benign. Am J Trop Med Hyg 2007; 77:79-87.
14. Maitland K, Williams TN, Bennett S, et al. The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu. Trans R Soc Trop Med Hyg 1996;90:614-20.
15. Genton B, al-Yaman F, Beck HP, et al. The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials, I: malariometric indices and immunity. Ann Trop Med Parasitol 1995; 89:359-76.
16. Karyana M, Burdarm L, Yeung S, et al. Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum. Malar J 2008; 7:148.
17. Ratcliff A, Siswantoro H, Kenangalem E, et al. Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chlo- roquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia. Trans R Soc Trop Med Hyg 2007; 101:351-9.
18. Hidayat M. Rapid survey on maternal mortality in Papua province. Papua, Indonesia: Provincial Health Office (PHO), 2001.
19. Tjitra E, Anstey NM, Sugiarto P, et al. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med 2008; 5:e128.
20. World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000; 94(Suppl 1):S1-90.
21. World Health Organization. WHO child growth standards: methods and development. Available at: http://www.who.int/childgrowth/stan- dards/weight-for-age/en/index.html. Accessed 28 July 2007.
22. Michon P, Cole-Tobian JL, Dabod E, et al. The risk of malarial infections and disease in Papua New Guinean children. Am J Trop Med Hyg 2007; 76:997-1008.
23. Poespoprodjo JR, Fobia W, Kenangalem E, et al. Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic. Clin Infect Dis 2008;46: 1374-81.
24. Woodberry T, Minigo G, Piera KA, et al. Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and cross-reactive responses. J Infect Dis 2008; 198:134-42.
25. Snow RW, Omumbo JA, Lowe B, et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 1997; 349:1650-4.
26. Looareesuwan S, Merry AH, Phillips RE, et al. Reduced erythrocyte survival following clearance of malarial parasitaemia in Thai patients. Br J Haematol 1987; 67:473-8.
27. Collins WE, Jeffery GM, Roberts JM. A retrospective examination of anemia during infection of humans with Plasmodium vivax. AmJTrop Med Hyg 2003;68:410-2.
28. Anstey NM, Russell B, Yeo TW, Price RN. The pathophysiology of vivax malaria. Trends Parasitol 2009 [Epub ahead of print].
29. Hasugian AR, Purba HL, Kenangalem E, et al. Dihydroartemisinin- piperaquine versus artesunate-amodiaquine: superior efficacy and post-treatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria. Clin Infect Dis 2007;44:1067-74.
30. Ratcliff A, Siswantoro H, Kenangalem E, et al. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet 2007; 369:757-65.
31. Caulfield LE, Richard SA, Black RE. Undernutrition as an underlying cause of malaria morbidity and mortality in children less than five years old. Am J Trop Med Hyg 2004; 71:55-63.
32. Williams TN, Maitland K, Phelps L, et al. Plasmodium vivax: a cause of malnutrition in young children. QJM 1997;90:751-7.
33. Bejon P, Berkley JA, Mwangi T, et al. Defining childhood severe fal- ciparum malaria for intervention studies. PLoS Med 2007; 4:e251.
34. Calis JC, Phiri KS, Faragher EB, et al. Severe anemia in Malawian children. N Engl J Med 2008; 358:888-99.
35. Greenwood B. Intermittent preventive antimalarial treatment in infants. Clin Infect Dis 2007;45:26-8.